R E Garner

964 total citations
28 papers, 760 citations indexed

About

R E Garner is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, R E Garner has authored 28 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in R E Garner's work include Antifungal resistance and susceptibility (10 papers), T-cell and B-cell Immunology (5 papers) and Antimicrobial Peptides and Activities (4 papers). R E Garner is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), T-cell and B-cell Immunology (5 papers) and Antimicrobial Peptides and Activities (4 papers). R E Garner collaborates with scholars based in United States, United Kingdom and Switzerland. R E Garner's co-authors include Judith E. Domer, John Hudson, Richard T. Sawyer, Klaus D. Elgert, Graham Lappin, B. Oosterhuis, W. J. Drijfhout, W. Kuhnz, R. Jochemsen and J Kneer and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

R E Garner

28 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R E Garner United States 15 230 219 157 150 116 28 760
K Neftel Switzerland 17 241 1.0× 231 1.1× 122 0.8× 204 1.4× 96 0.8× 42 1.2k
H Khayam-Bashi United States 17 153 0.7× 153 0.7× 115 0.7× 273 1.8× 59 0.5× 42 1.0k
Isabelle Seguin Canada 11 229 1.0× 307 1.4× 181 1.2× 278 1.9× 99 0.9× 13 943
S Looareesuwan Thailand 30 143 0.6× 374 1.7× 124 0.8× 165 1.1× 154 1.3× 67 1.9k
K Stenberg Sweden 15 201 0.9× 117 0.5× 250 1.6× 441 2.9× 81 0.7× 40 1.1k
Dennis L. Kasper United States 13 121 0.5× 122 0.6× 302 1.9× 139 0.9× 60 0.5× 31 887
Jennifer Lynn Ford United States 19 330 1.4× 126 0.6× 370 2.4× 177 1.2× 146 1.3× 47 1.1k
Patricia S. Watts United Kingdom 10 191 0.8× 161 0.7× 230 1.5× 163 1.1× 261 2.3× 10 1.2k
Katsuhisa Nakata Japan 15 96 0.4× 128 0.6× 204 1.3× 147 1.0× 103 0.9× 28 710
Wenwen Sun China 19 238 1.0× 93 0.4× 256 1.6× 237 1.6× 177 1.5× 82 923

Countries citing papers authored by R E Garner

Since Specialization
Citations

This map shows the geographic impact of R E Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Garner more than expected).

Fields of papers citing papers by R E Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Garner. The network helps show where R E Garner may publish in the future.

Co-authorship network of co-authors of R E Garner

This figure shows the co-authorship network connecting the top 25 collaborators of R E Garner. A scholar is included among the top collaborators of R E Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E Garner. R E Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ness, Traci L., John R. Lamb, Emily T. Norris, et al.. (2017). Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14. PLoS ONE. 12(12). e0189939–e0189939. 12 indexed citations
2.
Bai, Feng, Xue-Fen Pang, Lihui Zhang, et al.. (2016). Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis. Life Sciences. 153. 141–152. 42 indexed citations
3.
Arım, Rübab G., R E Garner, Jamie Brehaut, et al.. (2012). Contextual influences of parenting behaviors for children with neurodevelopmental disorders: results from a Canadian national survey. Disability and Rehabilitation. 34(26). 2222–2233. 25 indexed citations
4.
Lappin, Graham, W. Kuhnz, R. Jochemsen, et al.. (2006). Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs. Clinical Pharmacology & Therapeutics. 80(3). 203–215. 176 indexed citations
5.
Detmer, Kristina, et al.. (2004). Hedgehog signaling and cell cycle control in differentiating erythroid progenitors. Blood Cells Molecules and Diseases. 34(1). 60–70. 13 indexed citations
6.
McKee, Kelly T., et al.. (2000). Features of Urethritis in a Cohort of Male Soldiers. Clinical Infectious Diseases. 30(4). 736–741. 11 indexed citations
7.
Garner, R E & John Hudson. (1996). Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum. Infection and Immunity. 64(11). 4561–4566. 23 indexed citations
8.
Garner, R E, et al.. (1994). Secretion of TNF-α by alveolar macrophages in response to Candida albicans mannan. Journal of Leukocyte Biology. 55(2). 161–168. 87 indexed citations
9.
Sawyer, Richard T., R E Garner, & John Hudson. (1992). Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver. Infection and Immunity. 60(3). 1041–1046. 8 indexed citations
11.
Walker, Anna N., et al.. (1990). Immunocytochemical detection of chitin in Pneumocystis carinii. Infection and Immunity. 58(2). 412–415. 35 indexed citations
12.
Sawyer, Richard T., et al.. (1990). Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model. Infection and Immunity. 58(9). 2869–2874. 12 indexed citations
13.
Garner, R E, et al.. (1989). In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infection and Immunity. 57(6). 1800–1808. 37 indexed citations
14.
Domer, Judith E., et al.. (1989). Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infection and Immunity. 57(3). 693–700. 48 indexed citations
15.
Henderson, Lee A., et al.. (1988). Nonspecific and Candida-Specific Immune Responses in Mice Suppressed by Chronic Administration of Anti-μ. Journal of Leukocyte Biology. 44(5). 422–433. 12 indexed citations
16.
Domer, Judith E., Karen L. Elkins, David L. Ennist, et al.. (1987). Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein. Infection and Immunity. 55(11). 2619–2624. 10 indexed citations
17.
Garner, R E, et al.. (1987). Shifts in macrophage (Mφ) surface phenotypes during tumor growth: Association of Mac-2+ and Mac-3+ Mφ with immunosuppressive activity. Cellular Immunology. 108(2). 255–268. 33 indexed citations
18.
Elgert, Klaus D., et al.. (1987). Prostaglandin E2 Production by Mac-2+ Macrophages: Tumor-Induced Population Shift. Journal of Leukocyte Biology. 42(6). 673–681. 24 indexed citations
19.
Garner, R E & Klaus D. Elgert. (1986). Changes in Splenic Macrophage Mac Antigen Expression During Tumor Growth: A Kinetic Study of Accessory Cell Function and Antigen-Defined Phenotypes. Journal of Leukocyte Biology. 40(6). 709–724. 18 indexed citations
20.
Garner, R E, et al.. (1986). Variations in Macrophage Antigen Phenotype: A Correlation Between Ia Antigen Reduction and Immune Dysfunction During Tumor Growth. Journal of Leukocyte Biology. 40(5). 561–574. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026